Evaluating Virological Effects of Abacavir/Lamivudine with Darunavir as compared to Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients

Trial Profile

Evaluating Virological Effects of Abacavir/Lamivudine with Darunavir as compared to Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Lamivudine/abacavir (Primary) ; Darunavir; Ritonavir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Sep 2016 Results (n=676) published in the Clinical Drug Investigation
    • 24 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top